# FDA Inspection 1269612 - Cardinal Biologicals, Inc. - May 09, 2025

Source: https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/a3631d7e-0c07-4e48-b876-ab2582afed63
Source feed: FDA_Inspections

> FDA Inspection 1269612 for Cardinal Biologicals, Inc. on May 09, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269612
- Company Name: Cardinal Biologicals, Inc.
- Inspection Date: 2025-05-09
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Kansas City District Office

## Related Documents

- [FDA Inspection 1269612 - 2025-05-09](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/f6014819-a3b3-4cf9-9289-5ff24943e840)
- [FDA Inspection 1041210 - 2018-02-06](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/9ab8b0a5-4b06-4af9-9acd-1e0fac777f01)
- [FDA Inspection 974514 - 2016-05-24](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/caf18e3d-88e1-4bdb-a266-27596974db8d)
- [FDA Inspection 824267 - 2013-03-27](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/ae01f5ef-8f9a-4b42-a8c6-eefa15ff16b1)
- [FDA Inspection 824267 - 2013-03-27](https://www.keypedia.com/records/fda_inspections/cardinal-biologicals-inc/4f2f6060-84d4-4ba9-9054-e6f60be1bc98)

Company: https://www.keypedia.com/companies/cardinal-biologicals-inc/0afeaaa1-90e2-4642-9bf5-95bc060e9127

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79